Effective management and prevention of cardiometabolic diseases requires integration of digital health, nutrition, microbiome research, and multi-omics into a unified framework.
Tasa de eventos absoluta: 0% vs 0%
The global burden of cardiometabolic diseases-including obesity, type 2 diabetes, metabolic syndrome, and their associated cardiovascular symptoms such as hypertension and dyslipidemia continues to escalate, posing an urgent public health challenge. While rapid advances have been achieved across molecular biology, nutrition science, microbiome research, and digital health, these developments largely remain fragmented, limiting their real-world translational impact. This opinion article advances the central argument that isolated disciplinary advancements are insufficient to significantly reduce cardiometabolic disease unless deliberately integrated within a systems-level translational framework. We critically examine emerging domains-adipokine biomarkers, multi-omics-driven precision medicine, gut microbiome modulation, functional foods, and artificial intelligence (AI)- enabled digital health-not as independent solutions, but as interconnected components of a unified cardiometabolic care ecosystem. We further highlight key scientific, ethical, and translational roadblocks , including challenges in multi-omics integration, algorithmic bias in AI, regulatory barriers, and health equity considerations. By emphasizing functional integration rather than technological enumeration , this article proposes a pragmatic roadmap for interdisciplinary research, clinical implementation, and public policy alignment. To translate innovation into improvements in population-level cardiometabolic health, strategic investment in integrative infrastructures, interdisciplinary consortia, and implementation science is crucial. • Fragmentation is one of the main obstacles to cardiometabolic research, not a lack of creativity. • Digital health, nutrition, microbiome research, biomarkers, and multi-omics must all be integrated rather than separated. • Biomarker translation is made possible by artificial intelligence; however there are ethical and equity issues. • Effective management and prevention of cardiometabolic illness depend on systems-level integration. • Investments in implementation science that are in line with policy might hasten practical effects.
Gupta et al. (Sun,) reported a other. Effective management and prevention of cardiometabolic diseases requires integration of digital health, nutrition, microbiome research, and multi-omics into a unified framework.